FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

DESLORATADINE; PSEUDOEPHEDRINE SULFATE 24 HOUR

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 20 EU WC, 4 KDMF, 8 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

367 FDF Dossiers, 24 FDA Orange Book, 222 Europe, 6 Canada, 56 South Africa, 59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG, SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 6 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 28 BASF, 1 CD Formulation, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 39 Direct Compression, 35 Granulation, 34 Disintegrants & Superdisintegrants, 32 Taste Masking, 29 Thickeners and Stabilizers, 29 Controlled & Modified Release, 25 Lubricants & Glidants, 24 Solubilizers, 23 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 21 Parenteral, 17 Topical, 13 Co-Processed Excipients, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 7 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 38 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

28 APIs, 10 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 USP, 24 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
29/01/2026	Divis Laboratories	India	Divi's Laboratories Limited	62331-019	Desloratadine	2004-11-11	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)
29/01/2026	Matrix Pharmaceutical Inc	U.S.A	Matrix Pharmacorp Private Limited	84206-0027	DESLORATADINE	2024-08-08	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

DESLORATADINE; PSEUDOEPHEDRINE SULFATE 24 HOUR

DESLORATADINE; PSEUDOEPHEDRINE SULFATE 24 HOUR

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

14 USDMF

13 CEP/COS

4 JDMF

20 EU WC

4 KDMF

8 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

367 FDF Dossiers

24 FDA Orange Book

222 Europe

6 Canada

56 South Africa

59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG

SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem

5 Evonik

3 Rochem International Inc

23 SPI Pharma

1 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

6 Kirsch Pharma

1 Panvo Organics

1 ACG Worldwide

9 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

28 BASF

1 CD Formulation

12 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

29 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

2 Valens Pharmachem

4 Vasa Pharmachem

SOLUTION;ORAL - 0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons